Myeloproliferative disorders (MPDs) service

 

Cancer

Bone marrow biopsy from a patient with myelofibrosisMyeloproliferative disorders (MPDs) are rare conditions and may present in a number of different ways, including being found by chance after a routine blood test.

They are characterised by high levels of any or all blood cell counts, and are associated with risk of haemostatic complications (blood clotting and bleeding).  

In some patients, the bone marrow may fail and myelofibrosis or acute leukaemia may develop.

Our service

Normal bone marrow biopsy magnifiedWe offer regional specialist diagnosis, and conduct both international trials and local research.  The team works with dermatology, paediatrics (locally and in Oxford) and the Wessex Regional Genetics Laboratory as well as other centres of excellence worldwide. Many of our patients participate in trials.

The UK patient support group is run by both our team and patients.

Systemic mastocytosis is a rare myeloproliferative condition, and our centre is the only UK-based recognised centre for excellence in mast cell disorders in the European Network.  

 

Contact

Tel: 020 7188 2757

Research

Research leads to new treatments. Find out how you can get involved and help us improve patient care.

See some of our upcoming haematology clinical trials (Powerpoint 251Kb).